AprilBio Co.,Ltd. (KOSDAQ:397030)
South Korea
· Delayed Price · Currency is KRW 64,300
+1,100 (1.74%)
At close: Apr 28, 2026
AprilBio Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Cash & Equivalents | 7,073 | 3,347 | 6,587 | 7,284 | 24,377 | Upgrade
|
| Short-Term Investments | 85,698 | 91,135 | 57,000 | 61,500 | 30,000 | Upgrade
|
| Cash & Short-Term Investments | 92,771 | 94,482 | 63,587 | 68,784 | 54,377 | Upgrade
|
| Cash Growth | -1.81% | 48.59% | -7.56% | 26.50% | 217.40% | Upgrade
|
| Accounts Receivable | - | - | - | - | 4,292 | Upgrade
|
| Other Receivables | 1,360 | 1,634 | 480.02 | 255.83 | 147.07 | Upgrade
|
| Receivables | 1,360 | 1,634 | 480.02 | 255.83 | 4,439 | Upgrade
|
| Prepaid Expenses | 51.48 | 159.56 | 241.6 | 125.3 | 553.87 | Upgrade
|
| Other Current Assets | 531.27 | 350.12 | 2,419 | 193.49 | 25.34 | Upgrade
|
| Total Current Assets | 94,714 | 96,626 | 66,728 | 69,359 | 59,395 | Upgrade
|
| Property, Plant & Equipment | 1,046 | 1,200 | 1,337 | 1,337 | 1,667 | Upgrade
|
| Long-Term Investments | 341 | 999.95 | 11,000 | 0 | 0 | Upgrade
|
| Other Intangible Assets | 721.98 | 476.75 | 358.16 | 121.75 | 113.83 | Upgrade
|
| Other Long-Term Assets | 297.45 | 296.28 | 279.23 | 246.39 | 200.58 | Upgrade
|
| Total Assets | 97,120 | 99,599 | 79,702 | 71,065 | 61,376 | Upgrade
|
| Accrued Expenses | 129.29 | 312.18 | 176.74 | 150.45 | 401.88 | Upgrade
|
| Short-Term Debt | - | 2,740 | 5,472 | - | - | Upgrade
|
| Current Portion of Leases | 264.65 | 264.11 | 247.12 | 219.84 | 204.68 | Upgrade
|
| Other Current Liabilities | 147.58 | 5,166 | 15,849 | 1,417 | 3,439 | Upgrade
|
| Total Current Liabilities | 541.52 | 8,482 | 21,746 | 1,787 | 4,045 | Upgrade
|
| Long-Term Leases | 233.34 | 101.85 | 184.41 | 91.42 | 143.14 | Upgrade
|
| Other Long-Term Liabilities | 28.91 | 26.78 | 24.28 | 24.45 | 22.55 | Upgrade
|
| Total Liabilities | 803.77 | 8,611 | 21,954 | 1,903 | 4,211 | Upgrade
|
| Common Stock | 23,208 | 22,436 | 21,574 | 10,561 | 9,180 | Upgrade
|
| Additional Paid-In Capital | 151,799 | 137,481 | 126,746 | 135,659 | 116,365 | Upgrade
|
| Retained Earnings | -82,078 | -72,350 | -92,355 | -78,226 | -69,266 | Upgrade
|
| Comprehensive Income & Other | 3,387 | 3,422 | 1,782 | 1,168 | 887.2 | Upgrade
|
| Total Common Equity | 96,316 | 90,988 | 57,747 | 69,162 | 57,165 | Upgrade
|
| Shareholders' Equity | 96,316 | 90,988 | 57,747 | 69,162 | 57,165 | Upgrade
|
| Total Liabilities & Equity | 97,120 | 99,599 | 79,702 | 71,065 | 61,376 | Upgrade
|
| Total Debt | 497.99 | 3,106 | 5,904 | 311.26 | 347.82 | Upgrade
|
| Net Cash (Debt) | 92,273 | 91,377 | 57,683 | 68,473 | 54,030 | Upgrade
|
| Net Cash Growth | 0.98% | 58.41% | -15.76% | 26.73% | 219.95% | Upgrade
|
| Net Cash Per Share | 4069.21 | 4170.27 | 2701.12 | 3500.37 | 6479.89 | Upgrade
|
| Filing Date Shares Outstanding | 23.15 | 22.44 | 21.57 | 21.12 | 8.34 | Upgrade
|
| Total Common Shares Outstanding | 23.15 | 22.44 | 21.57 | 21.12 | 8.34 | Upgrade
|
| Working Capital | 94,172 | 88,144 | 44,982 | 67,572 | 55,350 | Upgrade
|
| Book Value Per Share | 4160.86 | 4055.51 | 2676.69 | 3274.38 | 6855.98 | Upgrade
|
| Tangible Book Value | 95,594 | 90,511 | 57,389 | 69,040 | 57,052 | Upgrade
|
| Tangible Book Value Per Share | 4129.67 | 4034.26 | 2660.09 | 3268.62 | 6842.33 | Upgrade
|
| Machinery | 2,535 | 2,493 | 2,176 | 2,072 | 1,908 | Upgrade
|
| Construction In Progress | - | - | - | - | 150 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.